From the National Library of Medicine and the National Institutes of Health
Contributed by The Department of Medicine, Standford School of Medicine, CA
OBJECTIVE. To compare the toxicities of commonly employed disease-modifying antirheumatic drugs (DMARDs) in rheumatoid arthritis (RA). METHODS. Toxicity Index scores, computed from symptoms, laboratory abnormalities, and hospitalizations attributable to DMARD therapy, were assessed in 2,747 patients. Read More
Welcome!
